TTrialPathMatch Me to Trials
← Back to trials
RecruitingSymptomatic Venous Thromboembolism (VTE)

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Eligible age

18+ yrs

Accepts

All genders

Locations

16 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery compared to acetylsalicylic acid. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

Sponsor: Regeneron Pharmaceuticals

Where it's recruiting

California

La Mesa · Rancho Mirage

Colorado

Lone Tree

Florida

Deerfield Beach · Miami · Tamarac

Illinois

Skokie

Indiana

Indianapolis

Kansas

Wichita

Maryland

Annapolis · Baltimore

New Jersey

Teaneck

New York

Rochester

North Carolina

Raleigh · Wilmington

Ohio

Cincinnati · Columbus

Source: ClinicalTrials.gov · NCT07213778 · last updated 2026-07-22

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylax · TrialPath